Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10597446 Method of treatment comprising purified recombinant IL-13 antibody

Patent 10597446 was granted and assigned to Genentech on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105974460

Date of Patent

March 24, 2020

Patent Application Number

158862770

Date Filed

February 1, 2018

Patent Citations Received

‌

US Patent 11369896 Methods for quantitating individual antibodies from a mixture

‌

US Patent 11884698 Systems and methods for preparing a polypeptide from a mixture

‌

US Patent 11850535 Methods for quantitating individual antibodies from a mixture

‌

US Patent 12070502 Process for reducing subvisible particles in a pharmaceutical formulation

‌

US Patent 11571636 Methods for quantitating individual antibodies from a mixture

‌

US Patent 11680930 Methods and systems for chromatography data analysis

‌

US Patent 11333642 Methods and systems for chromatography data analysis

Patent Primary Examiner

‌

Prema M Mertz

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10597446 Method of treatment comprising purified recombinant IL-13 antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API